This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Dec;95(12):3343-5.

doi: 10.1111/j.1572-0241.2000.03342.x.

Progress in understanding the mechanisms of action of 5-aminosalicylic acid

PMID: 11151859
DOI: 10.1111/j.1572-0241.2000.03342.x

Editorial

Progress in understanding the mechanisms of action of 5-aminosalicylic acid

R P MacDermott. Am J Gastroenterol. 2000 Dec.

. 2000 Dec;95(12):3343-5.

doi: 10.1111/j.1572-0241.2000.03342.x.

Author

PMID: 11151859
DOI: 10.1111/j.1572-0241.2000.03342.x

No abstract available

PubMed Disclaimer

Comment on

Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis.
Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K. Bantel H, et al. Am J Gastroenterol. 2000 Dec;95(12):3452-7. doi: 10.1111/j.1572-0241.2000.03360.x. Am J Gastroenterol. 2000. PMID: 11151876 Clinical Trial.

Similar articles

Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis.
Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K. Bantel H, et al. Am J Gastroenterol. 2000 Dec;95(12):3452-7. doi: 10.1111/j.1572-0241.2000.03360.x. Am J Gastroenterol. 2000. PMID: 11151876 Clinical Trial.
[Salazosulfapyridine and 5-aminosalicylic acid agents for the treatment of ulcerative colitis].
Aihara H, Hiwatashi N. Aihara H, et al. Nihon Rinsho. 1999 Nov;57(11):2476-80. Nihon Rinsho. 1999. PMID: 10572415 Review. Japanese.
Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease.
Nikolaus S, Fölscn U, Schreiber S. Nikolaus S, et al. Hepatogastroenterology. 2000 Jan-Feb;47(31):71-82. Hepatogastroenterology. 2000. PMID: 10690587 Review.
Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH, Munck LK. Nielsen OH, et al. Nat Clin Pract Gastroenterol Hepatol. 2007 Mar;4(3):160-70. doi: 10.1038/ncpgasthep0696. Nat Clin Pract Gastroenterol Hepatol. 2007. PMID: 17339853 Review.
In-vitro characterization of 5-aminosalicylic acid release from MMX mesalamine tablets and determination of tablet coating thickness.
Tenjarla S, Abinusawa A. Tenjarla S, et al. Adv Ther. 2011 Jan;28(1):62-72. doi: 10.1007/s12325-010-0087-5. Epub 2010 Nov 15. Adv Ther. 2011. PMID: 21088944

See all similar articles

Cited by

Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis.
Siddiqui A, Ancha H, Tedesco D, Lightfoot S, Stewart CA, Harty RF. Siddiqui A, et al. Dig Dis Sci. 2006 Apr;51(4):698-705. doi: 10.1007/s10620-006-3194-z. Dig Dis Sci. 2006. PMID: 16614991
5-Aminosalicylic Acid Inhibits Acute Clostridium difficile Toxin A-Induced Colitis in Rats.
Vigna SR. Vigna SR. Int J Inflam. 2014;2014:389621. doi: 10.1155/2014/389621. Epub 2014 Jun 23. Int J Inflam. 2014. PMID: 25045574 Free PMC article.
Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.
Gopal E, Miyauchi S, Martin PM, Ananth S, Roon P, Smith SB, Ganapathy V. Gopal E, et al. Pharm Res. 2007 Mar;24(3):575-84. doi: 10.1007/s11095-006-9176-1. Pharm Res. 2007. PMID: 17245649
An In Vitro Study Evaluating the Safety of Mesalazine on Human Nasoepithelial Cells.
Murphy W, Liu S, Javadiyan S, Vyskocil E, Feizi S, Callejas C, Wormald PJ, Vreugde S, Psaltis AJ. Murphy W, et al. Int J Mol Sci. 2024 Feb 28;25(5):2796. doi: 10.3390/ijms25052796. Int J Mol Sci. 2024. PMID: 38474043 Free PMC article.
Congestive ischemic colitis successfully treated with anti-inflammatory therapy: A case report.
Lee GW, Park SB. Lee GW, et al. World J Clin Cases. 2024 Jan 6;12(1):142-147. doi: 10.12998/wjcc.v12.i1.142. World J Clin Cases. 2024. PMID: 38292639 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- The Lens - Patent Citations Database